KWEB vs. XBI
KWEB (KraneShares CSI China Internet ETF) and XBI (SPDR S&P Biotech ETF) are both exchange-traded funds - KWEB is a China Equities fund tracking the CSI Overseas China Internet Index, while XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 10 years, KWEB returned -0.18%/yr vs 8.53%/yr for XBI. At a 0.42 correlation, their price movements are largely independent. KWEB charges 0.70%/yr vs 0.35%/yr for XBI.
Performance
KWEB vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KWEB achieves a -20.32% return, which is significantly lower than XBI's 9.42% return. Over the past 10 years, KWEB has underperformed XBI with an annualized return of -0.18%, while XBI has yielded a comparatively higher 8.53% annualized return.
KWEB
- 1D
- -0.33%
- 1M
- -4.91%
- YTD
- -20.32%
- 6M
- -22.46%
- 1Y
- -15.17%
- 3Y*
- 4.22%
- 5Y*
- -14.33%
- 10Y*
- -0.18%
XBI
- 1D
- 2.77%
- 1M
- -0.28%
- YTD
- 9.42%
- 6M
- 8.61%
- 1Y
- 62.35%
- 3Y*
- 15.65%
- 5Y*
- 1.14%
- 10Y*
- 8.53%
KWEB vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KWEB KraneShares CSI China Internet ETF | -20.32% | 23.55% | 12.01% | -9.06% | -17.24% | -49.01% | 58.23% | 29.92% | -33.80% | 69.73% |
XBI SPDR S&P Biotech ETF | 9.42% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Correlation
The correlation between KWEB and XBI is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Aug 2, 2013 | 0.42 |
The correlation between KWEB and XBI shifts across timeframes, from 0.28 (1 year) to 0.42 (all time), reflecting how their relationship changes across market environments.
KWEB vs. XBI - Sectors Allocation Comparison
Sectors
KWEB
XBI
Consumer Cyclical
-
Communication Services
-
Technology
-
Healthcare
Real Estate
-
Industrials
-
Consumer Defensive
-
Financial Services
Basic Materials
-
Energy
-
-
Utilities
-
-
Consumer Cyclical
KWEB
XBI
-
Communication Services
KWEB
XBI
-
Technology
KWEB
XBI
-
Healthcare
KWEB
XBI
Real Estate
KWEB
XBI
-
Industrials
KWEB
XBI
-
Consumer Defensive
KWEB
XBI
-
Financial Services
KWEB
XBI
Basic Materials
KWEB
-
XBI
Energy
KWEB
-
XBI
-
Utilities
KWEB
-
XBI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KWEB vs. XBI — Risk / Return Rank
KWEB
XBI
KWEB vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KraneShares CSI China Internet ETF (KWEB) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KWEB | XBI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.01 | ||
| Sortino ratioReturn per unit of downside risk | -4.00 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.40 | -0.47 |
| Calmar ratioReturn relative to maximum drawdown | -0.45 | 6.45 | -6.89 |
| Martin ratioReturn relative to average drawdown | -0.90 | 19.53 | -20.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| KWEB | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.56 | 2.45 | -3.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.30 | 0.04 | -0.34 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.00 | 0.27 | -0.27 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.06 | 0.36 | -0.30 |
Drawdowns
KWEB vs. XBI - Drawdown Comparison
The maximum KWEB drawdown since its inception was -80.92%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for KWEB and XBI.
Loading charts...
Drawdown Indicators
| KWEB | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.92% | -63.89% | -17.03% |
Max Drawdown (1Y)Largest decline over 1 year | -34.13% | -9.72% | -24.41% |
Max Drawdown (3Y)Largest decline over 3 years | -34.13% | -32.99% | -1.14% |
Max Drawdown (5Y)Largest decline over 5 years | -72.17% | -54.71% | -17.46% |
Max Drawdown (10Y)Largest decline over 10 years | -80.92% | -63.89% | -17.03% |
Current DrawdownCurrent decline from peak | -68.62% | -22.89% | -45.73% |
Average DrawdownAverage peak-to-trough decline | -35.25% | -20.93% | -14.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.97% | 3.20% | +13.77% |
Volatility
KWEB vs. XBI - Volatility Comparison
KraneShares CSI China Internet ETF (KWEB) has a higher volatility of 11.53% compared to SPDR S&P Biotech ETF (XBI) at 9.69%. This indicates that KWEB's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KWEB | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.53% | 9.69% | +1.84% |
Volatility (6M)Calculated over the trailing 6-month period | 20.09% | 20.31% | -0.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.25% | 25.60% | +1.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.67% | 32.20% | +15.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.98% | 32.00% | +7.98% |
KWEB vs. XBI - Expense Ratio Comparison
KWEB has a 0.70% expense ratio, which is higher than XBI's 0.35% expense ratio.
Dividends
KWEB vs. XBI - Dividend Comparison
KWEB's dividend yield for the trailing twelve months is around 7.73%, more than XBI's 0.33% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KWEB KraneShares CSI China Internet ETF | 7.73% | 6.16% | 3.51% | 1.71% | 0.00% | 7.07% | 0.29% | 0.08% | 3.40% | 0.58% | 1.19% | 0.46% |
XBI SPDR S&P Biotech ETF | 0.33% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
KWEB and XBI have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KWEB has higher volatility (11.53%) compared to XBI (9.69%). In terms of maximum drawdown, KWEB dropped -80.92% vs XBI's -63.89%.
On 10-year performance, XBI leads with 8.53% vs -0.18% for KWEB. On fees, XBI is cheaper at 0.35% per year. On volatility, XBI has been the lower-risk option at 9.69%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XBI has performed better with a 8.53% return vs -0.18%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XBI is cheaper with a 0.35% expense ratio, compared with 0.70% for KWEB.
KWEB has the higher dividend yield at 7.73%, compared with 0.33% for XBI.
KWEB is categorized as China Equities, while XBI is Health & Biotech Equities. KWEB tracks CSI Overseas China Internet Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: KraneShares and State Street. Their fees differ too: 0.70% for KWEB and 0.35% for XBI.
XBI currently has the higher Sharpe Ratio (2.45 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KWEB and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer